Strategic Acquisition Controlled Fluidics is now part of Ingersoll Rand, signaling access to a larger corporate backing, global procurement, and potential cross-selling opportunities for insulation, filtration, and fluid handling products to a broader customer base.

Regulated Industry Focus With decades of experience serving regulated spaces and offering design and first-article validation, there is a clear opportunity to position as a trusted partner for highly compliant medical devices and space-grade fluidic solutions to similar customers.

Supply Chain Stability Long-standing material partnerships and priority resin access reduce lead-time risk; target customers who fear supplier outages or material shortages and seek a dependable, single-point contact for resin and component sourcing.

Scalable Capacity Two production facilities totaling 30K square feet enable ramping from initial prototypes to full production; pitch to programs with volatile demand or upcoming ramps in diagnostics, space experiments, or instrument clusters.

Full-Spectrum Engagement In-house design, tolerancing, qualification, and first-article validation reduce program risk; pursue opportunities where customers want end-to-end accountability from concept to field deployment, especially where design reviews and quality gates are critical.